Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries (NCT06723392)
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries: A Randomized Controlled Trial of the Global Network for Women's and Children's Health Research
🩺 Plain-English Summary (8th-Grade Level)
This study, Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries (ABLE), is designed as a 2-arm randomized controlled trial (RCT) focused on pregnant individuals and newborn infants. A positive outcome of this study will contribute to global progress toward WHO Sustainable Development Goal Target 3.2 \[End preventable deaths of newborns and children under 5 years of age\] by examining the potential impact of this practice to reduce the incidence of SVN/SB and the lifelong health consequences associated with SVNs. In addition, the study will further explore the role and potential benefits of antibiotic treatment of AB in the pregnant individual. In total, 1,134 eligible participants, or approximately 162 per research site, will be randomized in the trial by the research teams in each of the seven international sites that, together with their United States of America (US) partners, participate in the Eunice Kennedy Shriver National Institute of Child Health and Human Development's (NICHD's) Global Network for Women's and Children's Health Research (GN).
Who can join: Review the eligibility criteria below.
Location: Icddr,B — Dhaka, Bangladesh
Age range: 18 Years to 49 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- Icddr,B — Dhaka, Bangladesh
- Kinshasa School of Public Health — Kinshasa, DRC
- Institue for Nutrition of Central America and Panama (INCAP) — Guatemala City, Departamento de Guatemala
- KLE Academy of Higher Education and Research — Belagavi, Karnataka
- Lata Medical Research Foundation — Nagpur, Maharashtra
- Aga Khan University — Karachi, Pakistan
- University Teaching Hospital — Lusaka, Zambia
📞 Contact the Study Coordinator
Phone: (880-2)9827001-10
Email: rhaque@icddrb.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Preterm Birth
- Targeting Human Milk Fortification to Improve Preterm Infant Growth and Brain Development — Boston, Massachusetts
- Omega Tots Long Term Follow-up — Columbus, Ohio
- Nurse-Family Partnership Impact Evaluation in South Carolina — Anderson, South Carolina
- Promoting Kangaroo Care for Preterm or Low Birthweight Infants in Rural India — Worcester, Massachusetts
- The Use of Wireless Sensors in Neonatal Intensive Care — Montreal, Quebec
- Music Intervention for Preterm Birth — New York, New York
Explore by condition: All Preterm Birth clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.